The global Methylmalonic Acidemia (MMA) market is projected to witness significant growth in the coming years. Valued at USD 9.16 billion in 2022, the market is expected to grow at a compound annual growth rate (CAGR) of 5.0% during the forecast period. This growth trajectory is attributed to increasing awareness about rare metabolic disorders, technological advancements in genetic...